Y-mAbs Therapeutics Inc. Stock Forecast
Y-mAbs Therapeutics Inc. stock price up 0.87% on Friday
(Updated on Apr 19, 2024)
The Y-mAbs Therapeutics Inc. stock price gained 0.87% on the last trading day (Friday, 19th Apr 2024), rising from $15.00 to $15.13. During the last trading day the stock fluctuated 4.77% from a day low at $14.71 to a day high of $15.41. The price has fallen in 6 of the last 10 days but is still up by 4.63% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 61 thousand more shares were traded than the day before. In total, 459 thousand shares were bought and sold for approximately $6.94 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 17.16% during the next 3 months and, with a 90% probability hold a price between $14.49 and $23.81 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
YMAB Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Y-mAbs Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $15.61. On a fall, the stock will find some support from the short-term average at $14.90. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -19.05%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Y-mAbs Therapeutics Inc. stock
Y-mAbs Therapeutics Inc. finds support from accumulated volume at $14.89 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.702 between high and low, or 4.77%. For the last week, the stock has had daily average volatility of 4.97%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (YMAB) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Y-mAbs Therapeutics Inc. to open at $15.08, and during the day (based on 14 day Average True Range), to move between $14.20 and $16.06, which gives a possible trading interval of +/-$0.93 (+/-6.17%) up or down from last closing price. If Y-mAbs Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 12.33% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $14.89 (1.59%) than the resistance at $16.19 (7.01%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Y-mAbs Therapeutics Inc. stock A Buy?
Y-mAbs Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -1.580 Sell Candidate Unchanged
Predicted Opening Price for Y-mAbs Therapeutics Inc. of Monday, April 22, 2024
| Fair opening price April 22, 2024 | Current price |
|---|---|
| $15.08 ( 0.312%) | $15.13 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for YMAB
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 15.78 | 4.33 % | |
| R2 | 15.52 | 2.55 % | ||
| R1 | 15.35 | 1.46 % | ||
| Current price: | 15.13 | |||
| Support | S1 | 14.81 | -2.08 % | |
| S2 | 14.65 | -3.18 % | ||
| S3 | 14.38 | -4.95 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 18.69 | 23.53 % | |
| R2 | 16.50 | 9.05 % | ||
| R1 | 16.19 | 7.01 % | ||
| Current price | 15.13 | |||
| Support | S1 | 14.89 | -1.59% | |
| S2 | 14.88 | -1.65% | ||
| S3 | 14.36 | -5.09% |
FAQ
Click here for our free guide on how to buy Y-mAbs Therapeutics Inc. Stock.
